|
시장보고서
상품코드
2078905
바이오프로세스 밸리데이션 시장 : 시험 종류별, 프로세스 구성요소별, 최종사용자별, 지역별Bioprocess Validation Market, By Test Type, By Process Component, By End User, By Geography |
||||||
바이오프로세스 밸리데이션 시장은 2026년에 6억 970만 달러 규모가 될 것으로 추정되며, 2033년까지 11억 8,060만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.9%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 6억 970만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 9.90% | 예측 금액(2033년) | 11억 8,060만 달러 |
바이오프로세스 밸리데이션(바이오프로세스 검증)이란, 설계 단계부터 상업 생산에 이르기까지의 데이터를 수집·평가하여, 해당 공정이 일관되게 고품질의 제품을 공급할 수 있음을 과학적으로 입증하는 것입니다. 이는 바이오의약품 제조에 관한 규제 요건입니다. 바이오프로세스 밸리데이션 시장은 바이오의약품 및 단일클론 항체에 대한 수요가 증가함에 따라 최근 몇 년간 눈부신 성장을 이루고 있습니다. 바이오의약품은 다양한 치료 분야에서 환자 관리와 치료에 혁명을 일으켰습니다. 바이오의약품의 승인 건수 및 생산량 증가에 따라, 이러한 복잡한 분자의 품질, 유효성, 안전성을 보장하기 위한 검증 활동이 활발해지고 있습니다. 미국 식품의약국(U.S. FDA)을 비롯한 각 규제 당국은 바이오프로세스 밸리데이션에 대해 엄격한 규제를 마련하고 있으며, 이것이 해당 시장의 성장을 뒷받침하고 있습니다.
시장 역학:
바이오프로세스 밸리데이션 시장의 성장은 업계 동향을 형성하는 다양한 요인들에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 바이오의약품에 대한 수요 증가입니다. 암이나 자가면역질환 등 만성 질환의 유병률이 증가함에 따라 첨단 바이오의약품이 개발되고 있으며, 이에 따라 견고한 바이오프로세스 밸리데이션 전략의 필요성이 대두되고 있습니다.
시장 성장에 기여하는 또 다른 요인은 미국 식품의약국(FDA)이나 유럽의약품청(EMA) 등 규제 당국의 엄격한 규제입니다. 이러한 규제로 인해 바이오의약품 제조업체들은 제조 공정의 유효성과 일관성을 입증해야 하며, 이것이 바이오프로세스 밸리데이션에 대한 수요를 이끌고 있습니다.
또한, 시장 참여자들의 인수합병 등 비유기적 성장 전략의 채택이 증가하고 있는 점도 예측 기간 동안 전 세계 바이오프로세스 밸리데이션 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2020년 4월, 전 세계 생명과학 및 진단 분야의 선도 기업인 다나허 코퍼레이션은 바이오의약품 개발 및 제조 솔루션을 강화하기 위해 크로마토그래피 시스템을 포함한 제너럴 일렉트릭(GE)의 생명과학 부문 내 바이오프로세스 사업을 인수했습니다.
그러나 이 시장에는 몇 가지 제약 사항도 존재합니다. 바이오 공정의 복잡한 특성과 표준화된 검증 프로토콜의 부재가 과제로 대두되고 있습니다. 바이오 공정의 개발과 검증에는 시간이 걸리며, 자원 및 인프라 측면에서 막대한 투자가 필요합니다. 게다가, 바이오프로세스 밸리데이션에 대한 전문 지식을 갖춘 숙련된 인력의 부족도 시장 성장을 더욱 저해하고 있습니다.
이러한 과제가 있음에도 불구하고, 시장에는 몇 가지 성장 기회가 존재합니다. 바이오 공정의 자동화 및 데이터 분석 분야의 기술 발전으로 인해, 검증 공정이 합리화되어 비용 절감과 효율 향상이 기대되고 있습니다. 또한, 맞춤형 의료에 대한 관심이 높아지고 있으며, 바이오 공정에서 일회용 기술의 도입이 확대되면서 시장 확대를 위한 새로운 길을 열어주고 있습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 바이오프로세스 밸리데이션 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 바이오프로세스 밸리데이션 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 바이오프로세스 밸리데이션 시장 : 시험 종류별(2021-2033년)
제5장 세계의 바이오프로세스 밸리데이션 시장 : 프로세스 구성요소별(2021-2033년)
제6장 세계의 바이오프로세스 밸리데이션 시장 : 최종사용자별(2021-2033년)
제7장 세계의 바이오프로세스 밸리데이션 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KSM 26.07.15Bioprocess Validation Market is estimated to be valued at USD 609.7 Mn in 2026 and is expected to reach USD 1,180.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 609.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.90% | 2033 Value Projection: | USD 1,180.6 Mn |
Bioprocess validation is the collection and evaluation of data, from the design stage through commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality product. It is a regulatory requirement for biopharmaceuticals manufacturing. The bioprocess validation market has been witnessing significant growth in recent years driven by the increasing demand for biologics and monoclonal antibodies. Biologics have revolutionized patient care and treatments across various therapeutic areas. Rising biologics approvals and production have been propelling validation activities to guarantee the quality, efficacy, and safety of such complex molecules. Various regulatory agencies including the U.S. Food and Drug Administration (U.S. FDA) have stringent regulations for bioprocess validation, facilitating the growth of this market.
Market Dynamics:
The bioprocess validation market growth is driven by various factors that are shaping the industry landscape. One of the primary drivers is the increasing demand for biopharmaceutical products. The growing prevalence of chronic diseases, such as cancer and autoimmune disorders, has led to the development of advanced biologics, thereby creating a need for robust bioprocess validation strategies.
Another factor contributing to market growth is the stringent regulations imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations require biopharmaceutical manufacturers to demonstrate the effectiveness and consistency of their manufacturing processes, driving the demand for bioprocess validation.
Moreover, the increasing adoption of inorganic activities such as acquisition by the market players is expected to drive the growth of the global bioprocess validation market over the forecast period. For instance, in April 2020, Danaher Corporation, a global life sciences and diagnostic innovator, acquired the bioprocessing business from General Electric's life sciences division, including chromatography systems, to enhance biologics development and manufacturing solutions.
However, the market does face some restraints. The complex nature of bioprocessing and the lack of standardized validation protocols pose challenges. The development and validation of bioprocesses are time-consuming and require substantial investments in terms of resources and infrastructure. Additionally, the scarcity of skilled professionals with expertise in bioprocess validation further impedes market growth.
Despite these challenges, the market experiences several opportunities for growth. Technological advancements in bioprocess automation and data analytics are anticipated to streamline the validation process, reducing costs and enhancing efficiency. Furthermore, the increasing focus on personalized medicine and the rising adoption of single-use technologies in bioprocessing offer new avenues for the market expansion.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- Key companies covered as a part of this study include Sartorius Stedim Biotech, Merck KGaA, Pall Corporation, Cobetter Filtration Equipment, Toxikon Corporation, DOC S.r.l., MEISSNER FILTRATION PRODUCTS, Thermo Fisher Scientific, SGS SA, Eurofins Scientific, Lonza Group, ProBioGen AG, Charles River Laboratories, Pacific BioLabs, Gibraltar Laboratories, Nelson Laboratories, BioProcess Technology Consultants, CMIC HOLDINGS Co., Ltd, Cytovance Biologics, and Wuxi Biologics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global bioprocess validation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioprocess validation market.
Bioprocess Validation Market Segmentation:
- By Test Type (Revenue, USD Mn, 2021 - 2033)
- Extractable Testing Services
- Microbiological Testing Services
- Physiochemical Testing Services
- Integrity Testing Services
- Others (Compatibility Testing Services and Others)
- By Process Component (Revenue, USD Mn, 2021 - 2033)
- Filter Elements
- Media containers and bags
- Freezing And Thawing Process Bags
- Bioreactors
- Transfer Systems
- Others (Mixing Systems and Others)
- By End User (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Contract Development & Manufacturing Organizations
- Academic and Research Institutes
- Other (Clinical Research Organizations and Others)
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in Bioprocess Validation Market:
- Sartorius Stedim Biotech
- Merck KGaA
- Pall Corporation
- Cobetter Filtration Equipment
- Toxikon Corporation
- DOC S.r.l.
- MEISSNER FILTRATION PRODUCTS
- Thermo Fisher Scientific
- SGS SA
- Eurofins Scientific
- Lonza Group
- ProBioGen AG
- Charles River Laboratories
- Pacific BioLabs
- Gibraltar Laboratories
- Nelson Laboratories
- BioProcess Technology Consultants
- CMIC HOLDINGS Co., Ltd
- Cytovance Biologics
- Wuxi Biologics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Bioprocess Validation, By Test Type
- Market Bioprocess Validation, By Process Component
- Market Bioprocess Validation, By End User
- Market Bioprocess Validation, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing demand for biopharmaceutical products
- Restraints
- Complex nature of bioprocessing
- Opportunities
- Technological advancements in bioprocess automation and data analytics
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Test Type launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Bioprocess Validation Market , By Test Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Extractable Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Microbiological Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Physiochemical Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Integrity Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others (Compatibility Testing Services and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Bioprocess Validation Market , By Process Component, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Filter Elements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Media containers and bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Freezing And Thawing Process Bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Transfer Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others (Mixing Systems and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Bioprocess Validation Market , By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Contract Development & Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other (Clinical Research Organizations and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Bioprocess Validation Market , By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Process Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- GCC Countries
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of Middle East
8. Competitive Landscape
- Sartorius Stedim Biotech
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pall Corporation
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cobetter Filtration Equipment
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Toxikon Corporation
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DOC S.r.l.
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Meissner Filtration Test Types
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SGS SA
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eurofins Scientific
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- ProBioGen AG
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Charles River Laboratories
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pacific BioLabs
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gibraltar Laboratories
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nelson Laboratories
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioProcess Technology Consultants
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CMIC HOLDINGS Co., Ltd
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cytovance Biologics
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Wuxi Biologics
- Company Highlights
- Test Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
